Reports
Sale
Global Isothermal Nucleic Acid Amplification Technology Market: By Technology: Helicase-dependent Amplification (HDA), Nicking Enzyme Amplification Reaction (NEAR), Loop-mediated Isothermal Amplification (LAMP), Others; By Products; By Target Type; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Isothermal Nucleic Acid Amplification Technology Market Outlook
The global isothermal nucleic acid amplification technology market size was valued at USD 4.56 billion in 2023, driven by the rising cases of pregnancy complications among women across the globe. The market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032 to achieve a value of USD 11.96 billion by 2032.
Isothermal Nucleic Acid Amplification Technology: Introduction
Isothermal amplification methods provide detection of a nucleic acid target sequence in a streamlined, exponential manner, and are not limited by the constraint of thermal cycling. Although these methods can vary considerably, they share some features in common.
Global Isothermal Nucleic Acid Amplification Technology Market Analysis
The key players are increasingly focusing on launching new products and kits, further propelling the market expansion. The increasing research and development activities are significantly aiding the isothermal nucleic acid amplification technology market growth.
According to a study, LAMP technology has been proven to be more effective in comparison with NAAT method as it can amplify target DNA rapidly and allows easy and fast detection of the target product. NAATs are routine laboratory techniques for the determination of disease agents. LAMP technology as a NAAT method allows for the amplification of target regions under isothermal conditions without the need for thermal cycling. It is a cost-effective method without the need for complicated instruments and high-cost laboratory infrastructure.
Global Isothermal Nucleic Acid Amplification Technology Market Segmentations
Market Breakup by Technology
- Helicase-dependent Amplification (HDA)
- Nicking Enzyme Amplification Reaction (NEAR)
- Loop-mediated Isothermal Amplification (LAMP)
- Strand Displacement Amplification (SDA)
- Nucleic Acid Sequence-based Amplification (NASBA)
- Transcription Mediated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Other Technologies
Market Breakup by Products
- Instruments
- Reagent
Market Breakup by Target Type
- Hospitals
- Research Organization
- Other End Users
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Isothermal Nucleic Acid Amplification Technology Market Overview
The market is witnessing significant growth driven by the rising prevalence of infectious diseases and cancer. The rising number of blood transfusion and donations, along with the increasing geriatric population across the globe, are some of the key factors which are propelling the growth of the market.
Increasing incidences of chronic diseases is also providing a crucial impetus to the market development. The rise in adoption of INAAT over PCR is due to the additional advantages it provides is further expected to propel the market growth. The high demand for low-cost and effective diagnostics procedures are also expected to add to the isothermal nucleic acid amplification technology market share. Isothermal technique is considered to be cost effective as it does not require to work on multiple temperatures and sample preparation, thus the demand for it has been rising.
North America is expected to lead the global market during the forecast period owing to the high incidence of chronic diseases. Continuous and effective technological advancement in isothermal nucleic acid amplification technology (INAAT) in the region has been propelling the market growth in the region. Moreover, the rising adoption of INAAT over conventional techniques in the region is also driving the global isothermal nucleic acid amplification technology market growth forward.
Isothermal Nucleic Acid Amplification Technology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Becton Dickinson and Company
- Qiagen NV
- bioMerieux
- Abbot Laboratories
- General ELectric
- OptiGene Limited
- Thermo Fisher Scientific
- Genomtec
- BioSystems
- PCR Biosystems
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Products |
|
| Breakup by Target Type |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Isothermal Nucleic Acid Amplification Technology Market Overview
3.1 Global Isothermal Nucleic Acid Amplification Technology Market Historical Value (2017-2023)
3.2 Global Isothermal Nucleic Acid Amplification Technology Market Forecast Value (2024-2032)
4 Global Isothermal Nucleic Acid Amplification Technology Market Landscape
4.1 Global Isothermal Nucleic Acid Amplification Technology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Isothermal Nucleic Acid Amplification Technology: Product Landscape
4.2.1 Analysis by Isotope
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Isothermal Nucleic Acid Amplification Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Isothermal Nucleic Acid Amplification Technology Market Segmentation
6.1 Global Isothermal Nucleic Acid Amplification Technology Market by Technology
6.1.1 Market Overview
6.1.2 Helicase-dependent Amplification (HDA)
6.1.3 Nicking Enzyme Amplification Reaction (NEAR)
6.1.4 Loop-mediated Isothermal Amplification (LAMP)
6.1.5 Strand Displacement Amplification (SDA)
6.1.6 Nucleic Acid Sequence-based Amplification (NASBA)
6.1.7 Transcription Mediated Amplification (TMA)
6.1.8 Single Primer Isothermal Amplification (SPIA)
6.1.9 Other Technologies
6.2 Global Isothermal Nucleic Acid Amplification Technology Market by Products
6.2.1 Market Overview
6.2.2 Instruments
6.2.3 Reagent
6.3 Global Isothermal Nucleic Acid Amplification Technology Market by Target Type
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Research Organisation
6.3.4 Other End Users
6.4 Global Isothermal Nucleic Acid Amplification Technology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Isothermal Nucleic Acid Amplification Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Isothermal Nucleic Acid Amplification Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America l Isothermal Nucleic Acid Amplification Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Becton Dickinson and Company
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Qiagen NV
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 bioMerieux
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Abbot Laboratories
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 General ELectric
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 OptiGene Limited
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Thermo Fisher Scientific
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Genomtec
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 BioSystems
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 PCR Biosystems
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 4.56 billion in 2023, driven by the increasing geriatric population.
The market is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, likely to reach a market value of USD 11.96 billion by 2032.
The growth of the market is driven by factors like rising technological advancements, growing product launches, and the rapidly advancing healthcare infrastructure.
The key trends aiding the market growth include the rising funding by the government and other organisations in the development of the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products available in the market include instruments and reagents.
Technologies used for the process are Helicase-dependent Amplification (HDA), Nicking Enzyme Amplification Reaction (NEAR), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Transcription Mediated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), among other technologies.
Hospitals and research organizations, among others are the key end-users in the market.
Key players involved in the market are Becton Dickinson and Company, Qiagen NV, bioMerieux, Abbot Laboratories, General Electric, OptiGene Limited, Thermo Fisher Scientific, Genomtec, BioSystems, and PCR Biosystems.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER